Literature DB >> 25048034

Diabetes: Gpr120 agonist has anti-inflammatory and insulin-sensitizing effects.

Claire Greenhill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25048034     DOI： 10.1038/nrendo.2014.118

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  1 in total

1.  A Gpr120-selective agonist improves insulin resistance and chronic inflammation in obese mice.

Authors:  Da Young Oh; Evelyn Walenta; Taro E Akiyama; William S Lagakos; Denise Lackey; Ariane R Pessentheiner; Roman Sasik; Nasun Hah; Tyler J Chi; Jason M Cox; Mary Ann Powels; Jerry Di Salvo; Christopher Sinz; Steven M Watkins; Aaron M Armando; Heekyung Chung; Ronald M Evans; Oswald Quehenberger; Joanne McNelis; Juliane G Bogner-Strauss; Jerrold M Olefsky
Journal:  Nat Med       Date:  2014-07-06       Impact factor: 87.241
  1 in total
  3 in total

1.  Association of blood n-3 fatty acid with bone mass and bone marrow TRAP-5b in the elderly with and without hip fracture.

Authors:  B-J Kim; H J Yoo; S J Park; M K Kwak; S H Lee; S J Kim; M W Hamrick; C M Isales; S H Ahn; J-M Koh
Journal:  Osteoporos Int       Date:  2019-02-04       Impact factor: 4.507

2.  GPR120: A bi-potential mediator to modulate the osteogenic and adipogenic differentiation of BMMSCs.

Authors:  Bo Gao; Qiang Huang; Qiang Jie; Wei-Guang Lu; Long Wang; Xiao-Jie Li; Zhen Sun; Ya-Qian Hu; Li Chen; Bao-Hua Liu; Jian Liu; Liu Yang; Zhuo-Jing Luo
Journal:  Sci Rep       Date:  2015-09-14       Impact factor: 4.379

3.  The GPR120 Agonist TUG-891 Inhibits the Motility and Phagocytosis of Mouse Alveolar Macrophages.

Authors:  Xing-Li Su; Ying-Guang Liu; Man Shi; Yan-Yan Zhao; Xiang-Yan Liang; Li-Jun Zhang; Lan-Lan Wei; Yu-Feng Zhao
Journal:  Biomed Res Int       Date:  2020-02-20       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.